COM:COHERUS
Coherus BioSciences
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.coherus.com/ipo date
Nov 06, 2014
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripali...Show More